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Edited by Beat ImhofAbstract Hypoxia-induced mitogenic factor (HIMF), also
known as FIZZ1 (found in inﬂammatory zone), plays important
roles in lung inﬂammation. We found that intraperitoneal injec-
tion of lipopolysaccharide (LPS) induced intensive HIMF
production exclusively in mouse lung, but not in the heart, liver,
spleen or kidney. This HIMF production, at least partly,
contributes to LPS-induced vascular cell adhesion molecule-1
(VCAM-1) upregulation and mononuclear cell sequestration to
lung parenchyma, while protecting alveolar type II cells from
LPS-resulted decrease in surfactant protein-C production and
cell death. These data indicate that HIMF participates in LPS-
induced acute lung injury and inﬂammation through modulating
VCAM-1 and SP-C expression.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lipopolysaccharide (LPS), or endotoxin, is a glycolipid that
constitutes to the major portion of the outermost membrane of
gram-negative bacteria. It is capable of inducing or exacerbat-
ing a variety of lung diseases, including acute lung injury (ALI)
[1]. ALI involves extensive inﬂammation, lung edema, and
alveolar hemorrhage [2]. Inﬂammatory cells migrate into the
lung parenchyma and release mediators (e.g., reactive oxygen
species, cytokines, and proteases), which destroy bacteria
and also cause tissue disruption and injury [3]. Simultaneously,
a repair process is initiated which replaces the seriously dam-
aged and dead cells. These competing cascades may reﬂect
the gene-inducing eﬀects of LPS. Recently, LPS has been
shown to upregulate 71 inﬂammation-associated genes in the
lung in a mouse model of LPS-induced ALI [4]. These include
naturally occurring competitive cytokine and/or chemokine
antagonists [4].*Corresponding author. Fax: +1 314 577 8859.
E-mail address: dli2@slu.edu (D. Li).
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doi:10.1016/j.febslet.2006.03.027In a mouse model of hypoxia-induced pulmonary hyperten-
sion, we identiﬁed a highly upregulated gene that we named
hypoxia-induced mitogenic factor (HIMF) [5]. HIMF has an
identical amino acid sequence to a protein called FIZZ1, de-
scribed in a mouse lung inﬂammation model [6]. In this model,
FIZZ1/HIMF mRNA and protein are found in the large air-
ways of control mice, where it is expressed at low levels in dis-
crete clusters of epithelial cells and peribronchial stroma [6].
During ovalbumin-induced pulmonary inﬂammation, FIZZ1/
HIMF expression is widespread, observed uniformly in the
bronchial mucosal epithelial cells, the alveolar type II cells,
and secreted into the brochoalveolar lavage ﬂuid [6]. Because
these studies indicate that FIZZ1/HIMF plays an important
role in lung inﬂammation, we hypothesized that HIMF partic-
ipates in the process of LPS-induced ALI. In the present study,
we investigated the eﬀects of LPS on HIMF production and
explored the possible roles of HIMF in LPS-induced ALI.2. Materials and methods
2.1. Animal experiments
Adult male C57BL/6 mice were obtained from Jackson Laborato-
ries. Mice in the LPS group (n = 6) were injected intraperitoneally with
10 lg/g (body weight) of Escherichia coli LPS (Serotype 055:B5, Sigma)
in phosphate-buﬀered saline (PBS), while control mice were injected
with only PBS (10 ll/g, n = 3). Recombinant HIMF protein puriﬁca-
tion and HIMF intratracheal instillation were performed as previously
reported [5,7]. All experiments followed the protocols approved by the
Animal Care and Use Committee of Johns Hopkins University.
2.2. Western blot for HIMF, VCAM-1, and SP-C
Tissue collection, homogenization, and cellular protein extraction
were performed as previously described [5,7]. Anti-HIMF antiserum
was generated with synthetic peptide [5]. Polyclonal antibodies for
VCAM-1 and SP-C were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). Protein electrophoresis, membrane transferring
and immunoblotting were performed as described previously [5,7,8].
2.3. Immunohistochemical staining for HIMF, VCAM-1, SP-C, CD45,
and apoptotic cells with M30 CytoDeath antibody
Lung samples were processed and immunostained as previously de-
scribed [5,7,8]. Polyclonal antibodies for VCAM-1, SP-C, and CD45
(Santa Cruz Biotechnology, 1:200 dilutions) were used for the staining.
For the quantiﬁcation of mononuclear cells in the lung parenchyma,
the numbers of CD45 positive cells were determined by counting ﬁve
random high power ﬁelds (HPF) and expressed as cell numbers/blished by Elsevier B.V. All rights reserved.
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nal M30 CytoDeath antibody, which detects cytokeratin 18 (a cyto-
skeletal protein) cleaved by Caspase 3 in apoptotic cells (Roche, 1:
100 dilution) [9], was applied.
2.4. RT-PCR for HIMF, VCAM-1 and SP-C
Total RNA was isolated with RNeasy Mini Kit (Qiagen). The re-
verse transcription reactions were conducted with Transcriptor First
Strand cDNA Synthesis Kit (Roche). Semi-quantitative RT-PCR
was performed using the PCR Master Mix System (Promega) with
primers shown in Table 1. The ratios between the ampliﬁed DNA frag-Table 1
Primer sequences of the examined genes and the expected length of the PCR
Name A/Sa Sequence (5 0
HIMF S TGA AGA CT
A TTA GGA CA
VCAM-1 S CCT CAC TT
A TTT TCC AA
SP-C S GCC TTC TC
A CCA GTA TC
GAPDH S GCC AAG GT
A GCC TGC TT
aS, sense; A, antisense.
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Fig. 1. Upregulation of HIMF and expression changes of VCAM-1 and
intraperitoneally with 10 lg/g of E. coli LPS in PBS (n = 6), while control m
points, the pattern of HIMF expression in diﬀerent organs was detected by W
tissues was further measured by Western blot (B) and RT-PCR (C). The symb
treated with saline only (P < 0.05), respectively.ments and GAPDH of each sample RNA were quantiﬁed by Phoretix
1 D software (Phoretix International Ltd.). For examination of SP-C
transcript changes in MLE-12, MLE-zeo, and MLE-HIMF cells,
real-time RT-PCR with SYBR Green PCR Master Mix (Applied Bio-
systems, Foster City, CA) was performed using ABI Prism 7700
Sequence Detector (Applied Biosystems).
2.5. RNAi construct for HIMF knockdown
Oligonucleotides encoding a short RNAi hairpin speciﬁc for HIMF
coding sequence were subcloned into pSuppressor (Imgenex). An-
nealed oligonucleotides were cloned downstream of U6 promoterfragments
ﬁ 3 0) Product (bp)
A CAA CTT GTT CCC 336
G TTG GCA GCA GCG
G CAG CAC TAC GGG CT 442
T ATC CTC AAT GAC GGG
A TCG TGG TTG T 388
A TGC CCT TCC T
C ATC CAT GAC AAC TTT GG 314
C ACC ACC TTC TTG ATG TC
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SP-C in LPS-induced ALI. Adult male C57BL/6 mice were injected
ice were injected with only PBS (10 ll/g, n = 3). At the indicated time
estern blot (A). The expression of HIMF, VCAM-1 and SP-C in lung
ols () and (#) indicate a signiﬁcant increase/decrease from control mice
Fig. 2. Immunohistochemical localization of HIMF, VCAM-1, and
SP-C in LPS-induced ALI. Mouse lung tissues from LPS-induced ALI
were collected and processed as paraﬃn sections for staining.
(A) HIMF expression is localized to alveolar type II cells (thick
arrows), airway epithelial cells (thin arrows), and vascular endothelial
cells (arrowheads). (B) The increased expression of VCAM-1 is within
vascular endothelial cells (upper panel, arrows) and SP-C expression in
alveolar type II cells (lower panel, arrows). (C) M30 CytoDeath
staining for LPS-induced apoptosis of alveolar type II cells (arrows).
Scale bars: 50 lm in (A) and (C); 100 lm in (B).
Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215 2209(primer 1 sequence, 5 0-TCGAACTATGAACAGATGGGCCTCCG-
AGTACTGGGAGGCCCATCTGTTCATAGTTTTTT-3 0; primer 2
sequence, 5 0-CTAGAAAAAACTATGAACAGATGGGCCTCCCA-
GTACTCGGAGGCCCATCTGTTCATAGT-3 0). The pSuppressor-
HIMF plasmid was veriﬁed by DNA sequencing analysis.
2.6. Cell culture and LPS stimulation
Mouse lung epithelial cell lineMLE-12 was cultured as previously de-
scribed [8]. SVEC 4- 10 (ATCC, CRL-2181), an SV40-transformedmur-
ine endothelial cell line, was grown in Dulbecco’s minimal Eagle’smedium (DMEM, Gibco Laboratories) supplemented with 10% fetal
bovine serum and antibiotics. Both cell lines were maintained at 37 C
inahumidiﬁedatmosphere of 5%CO2. Previous reports have shown that
PI-3K and MAP kinases participated in LPS-induced cytokine and
inﬂammatory mediator production [4,13–15]. For the examination of
possible signaling pathways involved in LPS-induced HIMF upregula-
tion, conﬂuent monolayer of cells were pretreated with signal transduc-
tion inhibitors LY294002, SB203580, PD98059 or U0126 (Calbiochem)
for 1 h, and then stimulated with LPS as indicated.
2.7. Generation of stable cell lines
The HIMF overexpressing lung epithelial cell line, MLE-HIMF, was
previously described [8]. HIMF RNAi or control vectors were co-
transfected with pcDNA3.1/Zeo (+) (Invitrogen) into SVEC 4–10 cells
with Lipofectamine 2000 (Life Technologies). Stable cell lines, named
as SVEC-HIMF RNAi, along with their transfection control (vector
only) cells, SVEC-Zeo, were screened based on resistance to Zeocin
(400 lg/ml).
2.8. Cell viability and apoptosis detection
Cell viability was monitored by the 2-(4,5-dimethyltriazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT, Sigma) colorimetric assay [10].
For the detection of apoptotic cells, the terminal deoxyribonucleotidyl
transferase-mediated deoxyuridine triphosphate-biotin nick-end label-
ing (TUNEL, Roche) method was performed. The rate of positively
stained cells was determined by calculating the average percentage of
the total cells per high power ﬁeld under a ﬂuorescent microscope (Flu-
overt, Leitz, Germany) linked with a Sony DX500 digital camera
(Sony, Tokyo, Japan).
2.9. Cell adherence assay
Mononuclear cells were isolated from heparinized mouse blood by
Ficoll-Paque (Amersham) density centrifugation, then labeled with
ﬂuorescein isothiocyanate (FITC)-conjugated antibody against CD45
(Vector Laboratories). Cells were stimulated with LPS for 12 h, and
incubated with 1 · 105 mononuclear cells for 30 min at 37 C with
5% CO2. For VCAM-1- blocking studies, the cells were preincubated
with anti-VCAM-1 antibody or control rabbit IgG (Santa Cruz Bio-
technology) in DMEM for 30 min at 37 C with 5% CO2 before addi-
tion of CD45-labelled cells. The number of adherent mononuclear cells
was determined by counting ﬁve random high power ﬁelds (HPF) and
expressed as cell numbers/HPF.3. Results
3.1. Upregulation of HIMF and accompanied changes of
VCAM-1 and SP-C in LPS-induced ALI
As shown in Fig. 1A, HIMF expression is observed at low
levels in the control lung and is not observed in the heart, liver,
spleen or kidney. Intraperitoneal injection of a nonlethal dose
(10 lg/g) of E. coli LPS, resulted in unique upregulation of
HIMF protein in the lung in a time-dependent manner
(Fig. 1A and B) and extensive inﬂammatory cell sequestration
in lung parenchyma (data not shown) as previously reported
[11]. HIMF production was further conﬁrmed at the mRNA le-
vel by RT-PCR (Fig. 1C). Immunohistochemical staining
(Fig. 2A) showed that HIMF upregulation was restricted to
alveolar type II cells (thick arrows), airway epithelial cells (thin
arrows) and vascular endothelial cells (arrowheads). As shown
in Fig. 1B and C, LPS strongly induced VCAM-1 production in
lung tissues, localized primarily to vascular endothelial cells
(Fig. 2B, arrows). Moreover, the expression of SP-C, a pulmon-
ary surfactant protein exclusively produced by alveolar type II
cells, was signiﬁcantly decreased in LPS-treated lung tissues
(Figs. 1B,C, and 2B), which was accompanied by increased
apoptosis of alveolar type II cells as demonstrated by positive
M30 CytoDeath staining (arrows in Fig. 2C).
Fig. 3. HIMF enhances VCAM-1 expression in vivo. Recombinant HIMF protein or FLAG peptide was intratracheally instilled into adult mouse
lungs (200 ng/animal in 40 ll saline, n = 6). Twenty-four hours later, VCAM-1 production in lung tissues was detected by Western blot (A) and RT-
PCR (B). Anti-CD45 immunohistochemical staining (C and D) was performed to assay mononuclear cell sequestration in lung tissues. In FLAG and
HIMF intratracheally instilled lung tissues, the numbers of CD45 positive cells were determined by counting ﬁve random high power ﬁelds (HPF)
and expressed as cell numbers/HPF. Scale bars: 100 lm. The symbol () indicates a signiﬁcant increase from control mouse lungs instilled with FLAG
peptide (P < 0.05).
2210 Q. Tong et al. / FEBS Letters 580 (2006) 2207–22153.2. HIMF enhanced VCAM-1 and SP-C expression in vivo
As shown in Fig. 3A and B, intratracheal instillation of
HIMF protein resulted in a signiﬁcant increase of VCAM-1
production in mouse lungs, accompanied by increased mono-
nuclear cell sequestration (Fig. 3C and D). In contrast, no
signiﬁcant VCAM-1 expression and mononuclear cell seque-
stration were observed in control mouse lungs treated with
FLAG peptide. Moreover, our previous studies demonstrated
that SP-C expression was signiﬁcantly enhanced in the lung
tissues intratracheally instilled with HIMF protein [8], indi-
cating that HIMF may have protective roles in LPS-induced
ALI.
3.3. LPS induced HIMF production in endothelial and lung
epithelial cells in vitro
Western blots indicate that LPS induced HIMF production
in SVEC 4-10 and MLE-12 cells in a dose- and time-dependent
manner (Fig. 4A and B). HIMF protein increase could be de-
tected as early as 1 h following LPS stimulation, even with only
1 lg/ml LPS. LPS-induced HIMF production was neitherabolished by phosphatidylinositol 3-kinase (PI-3K) inhibition
using LY294002, nor blocked by ERK1/2 MAPK and p38
MAPK inhibition using SB203580, U0126 and PD098099
(Fig. 4C).3.4. HIMF contributed to LPS-induced VCAM-1 production
and mononuclear cell adhesion
As shown in Fig. 5A, LPS administration dose-dependently
induced VCAM-1 production in SVEC 4-10 (endothelial) cells.
However, in HIMF-knockdown endothelial cells (SVEC-
HIMF RNAi), LPS-induced VCAM-1 production was attenu-
ated compared with those of counterpart controls (Fig. 5A).
As shown in Fig. 5B, LPS induced an increase in adherence
of mononuclear cells to SVEC 4-10. This was abolished by
blockage of VCAM-1 with a neutralizing antibody. Moreover,
this LPS-induced increase in mononuclear cell adherence to
SVEC-HIMF RNAi cells was also signiﬁcantly less than the
LPS-induced increase of mononuclear cell adherence to SVEC
cells (Fig. 5B).
Fig. 4. LPS induces HIMF production in endothelial and lung epithelial cells in vitro. (A) SVEC 4-10 and MLE-12 cells were incubated with diﬀerent
concentrations of LPS for 12 h. (B) SVEC 4-10 and MLE-12 cells were incubated with LPS (20 lg/ml) for various periods as indicated. (C) For the
detection of possibly involved signal transduction pathways in LPS-induced HIMF upregulation, SVEC 4-10 and MLE-12 cells were pretreated with
diﬀerent inhibitors for PI-3K, ERK1/2, and p38 MAPK for 1 h, then incubated with LPS (10 lg/ml) for 12 h. The HIMF protein production in
medium supernatant was assayed by Western blot.
Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215 22113.5. HIMF prevented lung epithelial MLE-12 cells from
LPS-induced SP-C downregulation and apoptosis
As shown in Fig. 6A, LPS administration decreased SP-C
mRNA levels in MLE-12 (alveolar type II) cells. Stable trans-
fection of these cells with HIMF cDNA (MLE-HIMF cells) in-
creased their expression of SP-C mRNA (Fig. 6A). However,
the magnitude of SP-C mRNA expression in MLE-HIMF cells
was dose-dependently decreased by LPS exposure (Fig. 6B).
Furthermore, LPS administration decreased cell viability and
induced apoptosis in MLE-12 cells (Fig. 7A, B and C). This
LPS-induced apoptosis was signiﬁcantly reduced by transfec-
tion of MLE-12 cells with HIMF (i.e. in MLE-HIMF cells)
(Fig. 7B and C).4. Discussion
LPS has been considered as the principal component in the
induction of ALI [12]. In the current study, we utilized a mur-ine model of intraperitoneal administration of LPS to mimic
the extrapulmonary infections and septicemia [11]; and to
examine the changes of HIMF, VCAM-1, and SP-C in the
lungs. This approach resulted in extensive inﬂammatory cell
sequestration in lung parenchyma (data not shown). More-
over, LPS induced intensive HIMF production in the lungs,
but not in other organs such as the brain, liver, heart or spleen.
Speciﬁcally, pulmonary expression of HIMF was noted in the
bronchial epithelial cells, alveolar type II cells, and vascular
endothelial cells, which was consistent with the ﬁndings in an
allergic model of pulmonary inﬂammation [6] and in the hyp-
oxic model of pulmonary hypertension [5]. These results fur-
ther demonstrated that HIMF might be a lung speciﬁc
growth factor or cytokine, which plays distinct roles in lung
inﬂammation by modulation pulmonary and vascular speciﬁc
gene expression. In cultured lung epithelial and endothelial cell
lines, HIMF protein increase can be detected as early as 1 h
after LPS administration, suggesting that HIMF may function
as an early responsive gene in pulmonary inﬂammation. Previ-
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Fig. 5. HIMF contributes to LPS-induced VCAM-1 production and adherence of mononuclear cells to endothelial cells. SVEC 4-10, SVEC-Zeo, and
SVEC-HIMF RNAi cells were stimulated with diﬀerent concentrations of LPS as indicated for 12 h. (A) HIMF and VCAM-1 expression was
detected by Western blot. (B) Cells were preincubated with anti- VCAM-1 antibody or control rabbit IgG, and incubated with CD45-FITC labeled
mononuclear cells for 30 min at 37 C with 5% CO2. The number of adherent mononuclear cells was determined by counting ﬁve random high power
ﬁelds. The symbols (*) and (#) indicate a signiﬁcant increase/decrease from controls untreated/treated with LPS (P < 0.05), respectively. The symbol
(,) indicates a signiﬁcant decrease from SVEC 4-10 controls (P < 0.05).
2212 Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215ous reports have indicated that PI-3K and MAPK signal trans-
duction pathways participate in LPS-induced cytokine produc-
tion [13–15]. Therefore, we further investigated whether these
pathways are also involved in LPS-induced HIMF upregula-
tion by chemical inhibitors. However, LPS-induced HIMF
production was not aﬀected by inhibition of PI-3K, ERK1/2
or p38 MAPK, which was consistent with our previous ﬁnd-
ings that these pathways are downstream of HIMF-mediated
signaling cascade [8]. These results indicate that other signal
transduction pathways divergent from PI-3K, ERK1/2, andp38 MAPK control the LPS-induced production of HIMF in
the pulmonary system.
Vascular cell adhesion molecule 1 (VCAM-1) is a 110 kDa
protein and a member of the immunoglobulin gene superfam-
ily, which participates in the recruitment of circulating mono-
cytes and lymphocytes into the inﬂammatory sites [16]. In the
present study, we found that VCAM-1 production in vascular
endothelium accompanies HIMF upregulation in lung tissues
of LPS-treated mice. To elucidate the cause and consequence
relationship between HIMF upregulation and VCAM-1
Co
n
tr
o
l
LP
S
10
μg
/m
l
LP
S
20
μg
/m
l
LP
S
40
μg
/m
l
Co
n
tr
o
l
LP
S
10
μg
/m
l
LP
S
20
μg
/m
l
LP
S
40
μg
/m
l
Co
n
tr
o
l
LP
S
10
μg
/m
l
LP
S
20
μg
/m
l
LP
S
40
μg
/m
l
MLE-12 MLE-Zeo MLE-HIMF
SP-C
GAPDH
0
2
4
6
8
MLE-12 MLE-zeo MLE-HIMF
Re
al
-
tim
e 
RT
-
PC
R
fo
r
SP
-
C 
m
RN
A 
le
ve
ls Control
LPS 10 ug/ml
LPS 20 ug/ml
LPS 40 ug/ml *
*
*
*
∇ ∇ ∇
∇ ∇ ∇
∇
∇
∇
A
B
Fig. 6. HIMF prevents lung epithelial MLE-12 cells from LPS-induced SP-C downregulation. MLE-12, MLE-Zeo, and MLE-HIMF cells were
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Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215 2213expression, HIMF protein was intratracheally instilled into
adult mice. This resulted in a signiﬁcant VCAM-1 production
in the pulmonary vascular endothelium, accompanied by sig-
niﬁcantly increased mononuclear cell sequestration in the lung
parenchyma. In addition, in vitro experiment with RNAi-med-
iated HIMF knockdown in endothelial cells led to a pro-
nounced decrease in LPS-induced VCAM-1 expression, and
followed by a signiﬁcantly reduced mononuclear cell adhesion.
These ﬁndings suggest that HIMF upregulation induced by
LPS, at least partially, contributes to VCAM-1 production
and mononuclear cell recruitment in LPS-induced ALI.
Alveolar damage is the predominant pathological ﬁnding in
ALI, and the magnitude of injury is closely associated with the
structural and functional deﬁciency of alveolar epithelial cells
[17]. In this study, we found that expression of surfactant pro-
tein C (SP-C), which plays an important role in the mainte-
nance of lung function [18], was signiﬁcantly decreased in
lung tissues of LPS-treated mice. However, Ingenito et al. re-
ported that SP-B expression was decreased and SP-C mRNA
level was not reduced at 24 h after intratracheal instillation
of LPS into mouse lungs [19]. We believe that the discrepancy
is due to the diﬀerences of LPS doses, routes of administration,
and time points examined after LPS-treatment. Up to now, themechanisms of LPS-mediated decrease in SP-C expression are
still not clear. Alveolar epithelial damage by LPS-induced
reactive oxygen species and inﬂammatory cytokines may be in-
volved in these processes, which warrants further investiga-
tions. In addition, the increased numbers of apoptotic
alveolar type II cells in the LPS-treated animal lung may con-
tribute to the reduced SP-C production in our present study. In
previous experiments from our laboratory, intratracheal instil-
lation of HIMF protein signiﬁcantly increased SP-C produc-
tion in lung tissues and our recent study also indicated that
HIMF overexpression increased SP-C production in cultured
alveolar type II cells [8]. However, LPS dose-dependently
attenuated the increase in SP-C production induced by
HIMF-overexpression. Thus, systemic administration of high
dose LPS appears to cause lung dysfunction by surpassing
the protective role of HIMF, and creating an environment
for tissue injury. Kitamura et al. recently found that alveolar
wall cells show signiﬁcant apoptotic changes in the early stages
of LPS-induced lung injury [20], which is consistent with our
ﬁndings from M30 CytoDeath immunohistochemical staining
[9]. The apoptotic M30 positive cells are mainly alveolar type
II cells in LPS-treated animal lungs, indicating that alveolar
type II cell death in the lung parenchyma may be the major
Fig. 7. HIMF prevents lung epithelial MLE-12 cells from LPS-induced cell viability inhibition and apoptosis. MLE-12, MLE-Zeo, and MLE-HIMF
cells were stimulated with diﬀerent concentrations of LPS for 24 h. (A) MTT colorimetry was performed to assay cell viabilities. (B) LPS-induced
apoptosis in cells was observed by TUNEL staining. (C) The apoptosis rates were determined by the average percentage of TUNEL-positive cells.
The symbols () and (#) indicate a signiﬁcant increase/decrease from MLE-12 controls (P < 0.05), respectively. Triplicate experiments were
performed with essentially identical results.
2214 Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215events accountable for SP-C reduction in LPS-induced ALI.
Furthermore, in our study, HIMF-overexpressing alveolar
type II cells respond to LPS exposure with less apoptosis than
their controls. In view of the evidences that HIMF plays
important roles in lung cell proliferation in compensatory lung
growth and antiapoptotic eﬀects during lung development
[5,7,21], it is conceivable to speculate that LPS-induced HIMF
production plays protective eﬀects in lung epithelial cells bypreventing apoptosis. Nevertheless, the mechanisms involved
in HIMF’s antiapoptotic eﬀects are still unknown. Further
studies are warranted to elucidate the signaling pathways in
HIMF-mediated cell survival, which will be beneﬁcial for the
prevention and therapy of LPS-induced ALI.
In summary, we have shown that LPS increases HIMF pro-
duction in mouse lung tissues, cultured endothelial, and lung
epithelial cell lines in a PI-3K-, ERK1/2- or p38 MAPK inde-
Q. Tong et al. / FEBS Letters 580 (2006) 2207–2215 2215pendent manner. As an early response gene in pulmonary
inﬂammation, the increased HIMF may partially contribute
to LPS-induced VCAM-1 production and mononuclear cell
recruitment to endothelium, while protecting lung epithelial
cells from LPS-related decrease in SP-C production, cell viabil-
ity inhibition and apoptosis.
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